 - Any other known malignancy within 3 years with the exception of non-melanoma skin cancer that had undergone curative treatment, cervical cancer in situ, or ductallobular carcinoma in situ of the breast that has underwent local treatment; consult the Cancer Therapy Evaluation Program CTEP medical monitor if unsure whether second malignancies meet the requirements specified above 